For help on how to get the results you want, see our search tips.
2 results
Medicine
Referrals Remove Referrals filter
Opinions on maximum residue limits Remove Opinions on maximum residue limits filter
Referral authorisation model
Centrally authorised product(s) Remove Centrally authorised product(s) filter
Centrally and nationally authorised products (mixed) Remove Centrally and nationally authorised products (mixed) filter
Referral decision making model
PRAC-CHMP-EC Remove PRAC-CHMP-EC filter
Referral status
Under evaluation Remove Under evaluation filter
-
List item
Referral: Janus Kinase inhibitors (JAKi) (updated)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Under evaluation, Last updated: 13/06/2022 -
List item
Referral: Nomegestrol and chlormadinone
nomegestrol, chlormadinone, associated names: Zoely, Article 31 referrals
Status: Under evaluation, Last updated: 10/05/2022